![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norov... HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection. Show more
BP plc (NYSE:BP) – BP expects weak margins in its refining business to impact its second-quarter profits by up to $700 million. The decline in refining margins, due to excess renewable...
The NEST-IN1 clinical study did not meet its primary or secondary efficacy endpoints, and the company will discontinue further development of HIL-214 in infants The company is exploring the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.04 | -2.1164021164 | 1.89 | 2.01 | 1.765 | 987560 | 1.8613461 | CS |
4 | -11.61 | -86.2555720654 | 13.46 | 15.25 | 1.55 | 2730663 | 2.10014886 | CS |
12 | -12.46 | -87.071977638 | 14.31 | 16.305 | 1.55 | 1036087 | 3.52156992 | CS |
26 | -13.68 | -88.0875724404 | 15.53 | 20.22 | 1.55 | 555334 | 5.23829208 | CS |
52 | -13.54 | -87.9792072775 | 15.39 | 20.22 | 1.55 | 322419 | 6.5453592 | CS |
156 | -16.91 | -90.1385927505 | 18.76 | 24.42 | 1.55 | 199206 | 8.92729206 | CS |
260 | -16.91 | -90.1385927505 | 18.76 | 24.42 | 1.55 | 199206 | 8.92729206 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions